Khaled Chatila, MD
Basic profileThe University of Texas Medical Branch at Galveston
Khaled Chatila is a Cardiology physician affiliated with The University of Texas Medical Branch at Galveston. OpenAlex indexes 84 publications with 1,301 citations (h-index 12).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
301 University Blvd
Galveston, TX 775555302
Telephone
409-772-2222Provider last certified this registry record 23 Jan 2020.
Industry payments
14 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Program year20251 payment
- Abbott LaboratoriesProgram year20251 payment
- Boston Scientific CorporationProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
69.9%Beta blocker15.4%Metoprolol Succinate55%Carvedilol34%Metoprolol Tartrate7%Sotalol4%Part D<11 patientsAldosterone antagonist (MRA)15%Spironolactone93%Eplerenone7%Part D<11 patients+ 13 more classes in this area
Metabolism & gastrointestinal
20.2%SGLT2 inhibitor16.1%Farxiga72%Jardiance28%Part D≥45 patientsPotassium supplement2.3%Potassium Chloride100%Part D≥14 patients+ 1 more class in this area
Blood & clotting
7.4%Factor Xa inhibitor5.4%Eliquis100%Part D≥29 patientsP2Y12 inhibitor2%Clopidogrel100%Part D≥14 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- OUTCOMES OF CONCOMITANT SURGICAL LEFT ATRIAL APPENDAGE EXCLUSION IN HYPERTROPHIC CARDIOMYOPATHY PATIENTS UNDERGOING CARDIAC SURGERY
Journal of the American College of Cardiology
2025 - A challenging case of eosinophilic myocarditis leading to heart failure and transplantation
Cardiovascular Pathology
2024 - Pharmacological management of heart failure in adults with congenital heart disease
Heart Failure Reviews
2024 - Successful Visceral and Parietal Pericardiectomy for Refractory Effusive-Constrictive Pericarditis: A Challenging Case Report
American Journal of Case Reports
2024
Similar KOLs
Other experts from the same institution or the same specialty.
A. White, MD
The University of Texas Medical Branch at Galveston
William Calhoun, MD
The University of Texas Medical Branch at Galveston
Ruth Bush, MD
The University of Texas Medical Branch at Galveston
Randall Urban, MD
The University of Texas Medical Branch at Galveston
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”